Traws Pharma Stock Price on October 3, 2024
| TRAW Stock | 13.49 2.71 25.14% |
Below is the normalized historical share price chart for Traws Pharma extending back to July 25, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Traws Pharma stands at 13.49, as last reported on the 27th of December, with the highest price reaching 13.49 and the lowest price hitting 10.78 during the day.
If you're considering investing in Traws Stock, it is important to understand the factors that can impact its price. Traws Pharma is dangerous given 3 months investment horizon. Traws Pharma owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.1, which indicates the firm had a 0.1% return per unit of risk over the last 3 months. We were able to analyze twenty-nine different technical indicators, which can help you to evaluate if expected returns of 2.04% are justified by taking the suggested risk. Use Traws Pharma Risk Adjusted Performance of 0.0746, coefficient of variation of 1221.23, and Semi Deviation of 4.28 to evaluate company specific risk that cannot be diversified away.
At this time, Traws Pharma's Liabilities And Stockholders Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to climb to about 511.3 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 15.7 M in 2024. . Price Earnings To Growth Ratio is likely to climb to 20.90 in 2024, whereas Price To Sales Ratio is likely to drop 1,113 in 2024. Traws Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 2nd of January 2001 | 200 Day MA 0.6214 | 50 Day MA 0.3792 | Beta 1.394 |
Traws |
Sharpe Ratio = 0.1032
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | TRAW | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 19.76 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.04 actual daily | 40 60% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 8 92% of assets perform better |
Based on monthly moving average Traws Pharma is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Traws Pharma by adding it to a well-diversified portfolio.
Price Book 1.6745 | Enterprise Value Ebitda 0.3293 | Price Sales 39.1656 | Shares Float 22.4 M | Wall Street Target Price 6.5 |
Related Headline
Entravision Communications Headline on 3rd of October 2024
Is Entravision Communications Corporation the Best Dividend ... by finance.yahoo.com
We recently compiled a list titled 10 Best Dividend Penny Stocks to Buy Now. In this article, we will look at where Entravision Communications Corporation ranks among the best dividend stocks to buy now. Penny stocks, typically defined as shares trading below 5, present a unique opportunity to investors who wish to buy stocks
Traws Pharma Valuation on October 3, 2024
It is possible to determine the worth of Traws Pharma on a given historical date. On October 3, 2024 Traws was worth 5.65 at the beginning of the trading date compared to the closed value of 5.55. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Traws Pharma stock. Still, in general, we apply an absolute valuation method to find Traws Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Traws Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Traws Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 5.60 | 5.70 | 5.13 | 5.70 | 9,411 | |
10/03/2024 | 5.65 | 5.72 | 5.35 | 5.55 | 7,784 |
| 5.47 | 5.84 | 5.47 | 5.53 | 5,295 |
| Backtest Traws Pharma | | | Traws Pharma History | | | Traws Pharma Valuation | Previous | Next |
Traws Pharma Trading Date Momentum on October 3, 2024
| On October 04 2024 Traws Pharma was traded for 5.53 at the closing time. The top price for the day was 5.84 and the lowest listed price was 5.47 . The trading volume for the day was 5.3 K. The trading history from October 4, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 0.36% . The trading price change against the current closing price is 6.49% . |
Traws Pharma Fundamentals Correlations and Trends
By evaluating Traws Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Traws Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Traws financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Traws Pharma Stock history
Traws Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Traws is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Traws Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Traws Pharma stock prices may prove useful in developing a viable investing in Traws Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 21 M | 15.7 M |
Traws Pharma Quarterly Net Working Capital |
|
Traws Pharma Stock Technical Analysis
Traws Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Traws Pharma Period Price Range
Low | December 27, 2024
| High |
0.00 | 0.00 |
Traws Pharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Traws Pharma December 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Traws Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Traws Pharma shares will generate the highest return on investment. By undertsting and applying Traws Pharma stock market strength indicators, traders can identify Traws Pharma entry and exit signals to maximize returns
Traws Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Traws Pharma's price direction in advance. Along with the technical and fundamental analysis of Traws Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Traws to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0746 | |||
| Jensen Alpha | 1.46 | |||
| Total Risk Alpha | 0.518 | |||
| Sortino Ratio | 0.303 | |||
| Treynor Ratio | 0.6418 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Traws Stock Analysis
When running Traws Pharma's price analysis, check to measure Traws Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Traws Pharma is operating at the current time. Most of Traws Pharma's value examination focuses on studying past and present price action to predict the probability of Traws Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Traws Pharma's price. Additionally, you may evaluate how the addition of Traws Pharma to your portfolios can decrease your overall portfolio volatility.